Printer's No. PN2527
See other bills
under the
same topic PRINTER'S NO. 2527 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.358 Session of 2025 INTRODUCED BY SCOTT, DALEY, SANCHEZ, HOWARD, KENYATTA AND GUENST, OCTOBER 24, 2025 REFERRED TO COMMITTEE ON HEALTH, OCTOBER 27, 2025 A RESOLUTIONRecognizing November 1, 2025, as "Tylenol Day" in Pennsylvania.WHEREAS, In 1884, two German physicians prescribed naphthalene to a patient they were treating for worms and a fever; andWHEREAS, The naphthalene did not relieve the patient's worms, but it did reduce the patient's fever, an effect that was not previously known; andWHEREAS, The physicians learned that the pharmacy had made a mistake and provided acetanilide, a compound isolated from coal tar; andWHEREAS, The physicians worked with a pharmaceutical firm to investigate the effects of acetanilide and confirmed that it reduced fever; andWHEREAS, After acetanilide was marketed as Antifebrin, users reported bluish skin after taking it; andWHEREAS, The cause of the bluish skin was identified as methemoglobinemia, a condition in which the oxygen transported 1234567891011121314151617 by hemoglobin is impaired; andWHEREAS, These findings led researchers to seek safer alternatives by altering the molecular structure of compounds to eliminate side effects; andWHEREAS, In 1887, a German company known as Bayer modified acetanilide to produce phenacetin, which did not cause methemoglobinemia; andWHEREAS, Later in 1887, a physician and a chemist worked together to find another derivative of acetanilide, now known as acetaminophen; andWHEREAS, The founders of acetaminophen recommended an extensive investigation into the medication before it became available to the public; andWHEREAS, The effectiveness and safety of acetaminophen as a fever and pain reliever were not confirmed until 1949, based on modern research techniques and clinical use in England; andWHEREAS, Because phenacetin was linked to kidney problems and aspirin to stomach problems, acetaminophen was promoted as the safer medication; andWHEREAS, In the late 1940s, McNeil Laboratories, a Philadelphia family-owned business, began studying the safety and efficacy of acetaminophen in hopes of marketing it for a future product; andWHEREAS, McNeil Laboratories began as a family-run pharmacy and later expanded into the manufacturing of prescription medicines; andWHEREAS, In 1955, McNeil Laboratories introduced Tylenol Elixir for Children after receiving approval by the United States Food and Drug Administration (FDA); andWHEREAS, Tylenol Elixir for Children was the first single-20250HR0358PN2527 - 2 - 123456789101112131415161718192021222324252627282930 ingredient acetaminophen product on the market and was available only by prescription; andWHEREAS, In 1959, Johnson & Johnson acquired McNeil Laboratories; andWHEREAS, In 1959, Tylenol was approved for sale without a prescription, leading to its availability over the counter the following year; andWHEREAS, Tylenol has become the best-known product of the more than 600 products on the market that contain the active ingredient acetaminophen; andWHEREAS, Tylenol has more than two dozen products in various forms, including liquids, dissolvable powders, chewable tablets, caplets and capsules; andWHEREAS, Each Tylenol product is formulated for different symptoms, age groups and delivery methods; andWHEREAS, Tylenol offers products for pain and fever relief, as well as for arthritis, cold and flu symptoms, sinus relief and sleep; andWHEREAS, It is estimated that nearly 25% of adults in the United States use a medication containing acetaminophen each week; andWHEREAS, Tylenol is the number one doctor-recommended pain reliever brand; andWHEREAS, The year 2025 commemorates the 70th anniversary of Tylenol receiving FDA approval and being introduced by McNeil Laboratories; therefore be itRESOLVED, That the House of Representatives recognize November 1, 2025, as "Tylenol Day" in Pennsylvania.20250HR0358PN2527 - 3 - 12345678910111213141516171819202122232425262728
under the
same topic PRINTER'S NO. 2527 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.358 Session of 2025 INTRODUCED BY SCOTT, DALEY, SANCHEZ, HOWARD, KENYATTA AND GUENST, OCTOBER 24, 2025 REFERRED TO COMMITTEE ON HEALTH, OCTOBER 27, 2025 A RESOLUTIONRecognizing November 1, 2025, as "Tylenol Day" in Pennsylvania.WHEREAS, In 1884, two German physicians prescribed naphthalene to a patient they were treating for worms and a fever; andWHEREAS, The naphthalene did not relieve the patient's worms, but it did reduce the patient's fever, an effect that was not previously known; andWHEREAS, The physicians learned that the pharmacy had made a mistake and provided acetanilide, a compound isolated from coal tar; andWHEREAS, The physicians worked with a pharmaceutical firm to investigate the effects of acetanilide and confirmed that it reduced fever; andWHEREAS, After acetanilide was marketed as Antifebrin, users reported bluish skin after taking it; andWHEREAS, The cause of the bluish skin was identified as methemoglobinemia, a condition in which the oxygen transported 1234567891011121314151617 by hemoglobin is impaired; andWHEREAS, These findings led researchers to seek safer alternatives by altering the molecular structure of compounds to eliminate side effects; andWHEREAS, In 1887, a German company known as Bayer modified acetanilide to produce phenacetin, which did not cause methemoglobinemia; andWHEREAS, Later in 1887, a physician and a chemist worked together to find another derivative of acetanilide, now known as acetaminophen; andWHEREAS, The founders of acetaminophen recommended an extensive investigation into the medication before it became available to the public; andWHEREAS, The effectiveness and safety of acetaminophen as a fever and pain reliever were not confirmed until 1949, based on modern research techniques and clinical use in England; andWHEREAS, Because phenacetin was linked to kidney problems and aspirin to stomach problems, acetaminophen was promoted as the safer medication; andWHEREAS, In the late 1940s, McNeil Laboratories, a Philadelphia family-owned business, began studying the safety and efficacy of acetaminophen in hopes of marketing it for a future product; andWHEREAS, McNeil Laboratories began as a family-run pharmacy and later expanded into the manufacturing of prescription medicines; andWHEREAS, In 1955, McNeil Laboratories introduced Tylenol Elixir for Children after receiving approval by the United States Food and Drug Administration (FDA); andWHEREAS, Tylenol Elixir for Children was the first single-20250HR0358PN2527 - 2 - 123456789101112131415161718192021222324252627282930 ingredient acetaminophen product on the market and was available only by prescription; andWHEREAS, In 1959, Johnson & Johnson acquired McNeil Laboratories; andWHEREAS, In 1959, Tylenol was approved for sale without a prescription, leading to its availability over the counter the following year; andWHEREAS, Tylenol has become the best-known product of the more than 600 products on the market that contain the active ingredient acetaminophen; andWHEREAS, Tylenol has more than two dozen products in various forms, including liquids, dissolvable powders, chewable tablets, caplets and capsules; andWHEREAS, Each Tylenol product is formulated for different symptoms, age groups and delivery methods; andWHEREAS, Tylenol offers products for pain and fever relief, as well as for arthritis, cold and flu symptoms, sinus relief and sleep; andWHEREAS, It is estimated that nearly 25% of adults in the United States use a medication containing acetaminophen each week; andWHEREAS, Tylenol is the number one doctor-recommended pain reliever brand; andWHEREAS, The year 2025 commemorates the 70th anniversary of Tylenol receiving FDA approval and being introduced by McNeil Laboratories; therefore be itRESOLVED, That the House of Representatives recognize November 1, 2025, as "Tylenol Day" in Pennsylvania.20250HR0358PN2527 - 3 - 12345678910111213141516171819202122232425262728
Texto oficial de la Legislatura de Pennsylvania. El formato se adaptó para leerlo en Ratifi.